Molecular pharmacological studies on renal sodium/glucose co-transporters inhibitors

Simple item page
dc.contributor.authorMohammed Ali Fahad Alhamamah
dc.date2017
dc.date.accessioned2022-05-18T11:57:52Z
dc.date.available2022-05-18T11:57:52Z
dc.degree.departmentالطب البيطري والثروة الحيوانية
dc.degree.grantorKing Faisal University
dc.description.abstractABSTRACT The sodium/glucose co-transporter (SGLT) inhibitors are new potent antdiabetic drugs by acting on glucose transport system in kidneys. Every day, the kidneys almost return about 180 grams of sugar into the body by reabsorption in the proximal convoluted tubules. SGLTs share in glucose reabsorption by moving glucose into the interior of renal cells. Therefore, inhibition of SGLTs will lead to marked loss of glucose into urine and aid in the control of hyperglycemia regardless the status
dc.identifier.other1299
dc.identifier.urihttps://drepo.sdl.edu.sa/handle/20.500.14154/3519
dc.language.isoen
dc.publisherSaudi Digital Library
dc.thesis.levelMaster
dc.thesis.sourceKing Faisal University
dc.titleMolecular pharmacological studies on renal sodium/glucose co-transporters inhibitors
dc.typeThesis
Files
Collections